US 11465994
MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions
granted A61KA61K31/353A61K31/397
Quick answer
US patent 11465994 (MGluR7 agonist compounds for treating mGluR7-regulated diseases, disorders, or conditions) held by Takeda Pharmaceutical Company Limited expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/353, A61K31/397, A61K31/4025, A61K31/4433